These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29904758)

  • 1. Correction: 2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition.
    Nepali K; Kumar S; Huang HL; Kuo FC; Lee CH; Kuo CC; Yeh TK; Li YH; Chang JY; Liou JP; Lee HY
    Org Biomol Chem; 2018 Jul; 16(25):4734. PubMed ID: 29904758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibition.
    Nepali K; Kumar S; Huang HL; Kuo FC; Lee CH; Kuo CC; Yeh TK; Li YH; Chang JY; Liou JP; Lee HY
    Org Biomol Chem; 2016 Jan; 14(2):716-723. PubMed ID: 26694589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Amino-2-aroylquinolines as highly potent tubulin polymerization inhibitors.
    Nien CY; Chen YC; Kuo CC; Hsieh HP; Chang CY; Wu JS; Wu SY; Liou JP; Chang JY
    J Med Chem; 2010 Mar; 53(5):2309-13. PubMed ID: 20148562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives.
    Kim T; Keum G; Pae AN
    Expert Opin Ther Pat; 2013 Aug; 23(8):919-43. PubMed ID: 23641970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunofluorescence colocalization of the 90-kDa heat-shock protein and microtubules in interphase and mitotic mammalian cells.
    Redmond T; Sanchez ER; Bresnick EH; Schlesinger MJ; Toft DO; Pratt WB; Welsh MJ
    Eur J Cell Biol; 1989 Oct; 50(1):66-75. PubMed ID: 2693091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat-shock protein 90 (hsp90) binds in vitro to tubulin dimer and inhibits microtubule formation.
    Garnier C; Barbier P; Gilli R; Lopez C; Peyrot V; Briand C
    Biochem Biophys Res Commun; 1998 Sep; 250(2):414-9. PubMed ID: 9753644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer activity of methylene blue via inhibition of heat shock protein 70.
    Sanchala D; Bhatt LK; Pethe P; Shelat R; Kulkarni YA
    Biomed Pharmacother; 2018 Nov; 107():1037-1045. PubMed ID: 30257315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X66, a novel N-terminal heat shock protein 90 inhibitor, exerts antitumor effects without induction of heat shock response.
    Zhao Z; Zhu J; Quan H; Wang G; Li B; Zhu W; Xie C; Lou L
    Oncotarget; 2016 May; 7(20):29648-63. PubMed ID: 27105490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxotere-induced inhibition of human endothelial cell migration is a result of heat shock protein 90 degradation.
    Murtagh J; Lu H; Schwartz EL
    Cancer Res; 2006 Aug; 66(16):8192-9. PubMed ID: 16912198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.
    Kumalo HM; Bhakat S; Soliman ME
    Chem Biol Drug Des; 2015 Nov; 86(5):1131-60. PubMed ID: 25958815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Class of Hsp90 C-Terminal Modulators Have Pre-Clinical Efficacy in Prostate Tumor Cells Without Induction of a Heat Shock Response.
    Armstrong HK; Koay YC; Irani S; Das R; Nassar ZD; ; Selth LA; Centenera MM; McAlpine SR; Butler LM
    Prostate; 2016 Dec; 76(16):1546-1559. PubMed ID: 27526951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of natural and synthetic inhibitors to human heat shock protein 90 and their clinical application.
    Petrikaitė V; Matulis D
    Medicina (Kaunas); 2011; 47(8):413-20. PubMed ID: 22123555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hsp70 inhibiting peptide aptamer A17 potentiates radiosensitization of tumor cells by Hsp90 inhibition.
    Schilling D; Garrido C; Combs SE; Multhoff G
    Cancer Lett; 2017 Apr; 390():146-152. PubMed ID: 28108313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock protein 90: a unique chemotherapeutic target.
    Cullinan SB; Whitesell L
    Semin Oncol; 2006 Aug; 33(4):457-65. PubMed ID: 16890800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reinventing Hsp90 Inhibitors: Blocking C-Terminal Binding Events to Hsp90 by Using Dimerized Inhibitors.
    Koay YC; Wahyudi H; McAlpine SR
    Chemistry; 2016 Dec; 22(51):18572-18582. PubMed ID: 27859703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors.
    Zaarur N; Gabai VL; Porco JA; Calderwood S; Sherman MY
    Cancer Res; 2006 Feb; 66(3):1783-91. PubMed ID: 16452239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
    Hall JA; Seedarala S; Rice N; Kopel L; Halaweish F; Blagg BS
    J Nat Prod; 2015 Apr; 78(4):873-9. PubMed ID: 25756299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Synthesis and immunological evaluation of MUC1 glycopeptide conjugates bearing N-acetyl modified STn derivatives as anticancer vaccines.
    Xiao A; Zheng XJ; Song C; Gui Y; Huo CX; Ye XS
    Org Biomol Chem; 2017 Mar; 15(9):2120-2121. PubMed ID: 28195591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor selectivity of a novel tubulin and HSP90 dual-targeting inhibitor in non-small cell lung cancer models.
    Zhang Q; Zhai S; Li L; Li X; Zhou H; Liu A; Su G; Mu Q; Du Y; Yan B
    Biochem Pharmacol; 2013 Aug; 86(3):351-60. PubMed ID: 23743233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that the 90-kilodalton heat shock protein is associated with tubulin-containing complexes in L cell cytosol and in intact PtK cells.
    Sanchez ER; Redmond T; Scherrer LC; Bresnick EH; Welsh MJ; Pratt WB
    Mol Endocrinol; 1988 Aug; 2(8):756-60. PubMed ID: 3062385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.